Uploaded November 2024 | Updated September 2026, 1 week ago
Learn about emerging research on improvements in clinical understanding that can be gained by applying findings from the neurosciences field.
Free certificates of participation are available upon successful completion of a brief knowledge quiz at autism.org/applying-neuroscience
James McPartland, Ph.D., is the Harris Professor of Child Psychiatry and Psychology at the Yale Child Study Center. He is a neuroscientist and practicing child psychologist who directs the Yale Developmental Disabilities Clinic. Dr. McPartland is also a founder and director of the Yale Center for Brain and Mind Health and the Principal Investigator of the Autism Biomarkers Consortium for Clinical Trials, a US-based effort to identify biological indices to enhance intervention research in autism. Dr. McPartland’s program of research investigates the brain bases of neurodevelopmental conditions to develop biologically-based tools to improve clinical care and quality of life for autistic people and their families.
In this webinar:
5:00 – The need for biomarkers in autism
11:00 – Practical considerations for clinical practice
13:30 – EEGs as a promising biomarker technology
20:00 – The N170 biomarker
28:00 – N170: social and behavioral development
34:00 – Confounds and responses to behavioral interventions
42:00 – Autism Biomarkers Consortium for Clinical Trials (ABC-CT)
47:00 – ABC-CT progress and impact
54:00 – Implications for clinical practice
Learn about emerging research on improvements in clinical understanding that can be gained by applying findings from the neurosciences field.
Free certificates of participation are available upon successful completion of a brief knowledge quiz at autism.org/applying-neuroscience
James McPartland, Ph.D., is the Harris Professor of Child Psychiatry and Psychology at the Yale Child Study Center. He is a neuroscientist and practicing child psychologist who directs the Yale Developmental Disabilities Clinic. Dr. McPartland is also a founder and director of the Yale Center for Brain and Mind Health and the Principal Investigator of the Autism Biomarkers Consortium for Clinical Trials, a US-based effort to identify biological indices to enhance intervention research in autism. Dr. McPartland’s program of research investigates the brain bases of neurodevelopmental conditions to develop biologically-based tools to improve clinical care and quality of life for autistic people and their families.
In this webinar:
5:00 – The need for biomarkers in autism
11:00 – Practical considerations for clinical practice
13:30 – EEGs as a promising biomarker technology
20:00 – The N170 biomarker
28:00 – N170: social and behavioral development
34:00 – Confounds and responses to behavioral interventions
42:00 – Autism Biomarkers Consortium for Clinical Trials (ABC-CT)
47:00 – ABC-CT progress and impact
54:00 – Implications for clinical practice
